Comment: PF-07258669's chemical structure was revealed during the first disclosures session at the 2022 ACS meeting in Chicago. This is Pfizer's melanocortin 4 receptor (MC4R) antagonist. Blocking MC4R activation is proposed as a mechanism to increase weight gain, and Pfizer intend this agent to be used to treat geriatric anorexia.
|
|
2D Structure
|
|
Physico-chemical Properties
|
|
Hydrogen bond acceptors
|
7
|
Hydrogen bond donors
|
1
|
Rotatable bonds
|
5
|
Topological polar surface area
|
93.13
|
Molecular weight
|
462.22
|
XLogP
|
2.52
|
No. Lipinski's rules broken
|
0
|
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
COc1ncc(c(c1)[C@H](C(=O)N1CC[C@]2(C1)CCc1c(N2)nc(c(c1)c1ncccn1)C)C)F
|
Isomeric SMILES
|
Cc1c(cc2CC[C@@]3(CCN(C3)C(=O)[C@H](C)c3cc(ncc3F)OC)Nc2n1)c1ncccn1
|
InChI
|
InChI=1S/C25H27FN6O2/c1-15(18-12-21(34-3)29-13-20(18)26)24(33)32-10-7-25(14-32)6-5-17-11-19(16(2)30-22(17)31-25)23-27-8-4-9-28-23/h4,8-9,11-13,15H,5-7,10,14H2,1-3H3,(H,30,31)/t15-,25+/m1/s1
|
InChI Key
|
PARGFYLSRQUWHR-BZQUYTCOSA-N
|
|
|